JAMA · 1998 · 158 citations · 0 references
Medicinal ChemistryAntiviral TherapyImmunologyPharmacologyMolecular LevelVirologyAntiviral Drug DevelopmentBiological TherapyNew ClassDisease-causing ProteinsAntisense TherapyTherapeutic AreaAntiviral DrugDrug DevelopmentMedicineDrug DiscoveryDrug Resistance
A NEW CLASS of therapeutic agents known as "antisense" drugs is likely to become available to physicians within the next few months. These drugs operate at the molecular level, interrupting the process by which disease-causing proteins are produced.